Role of genomics in assessing risk, especially in ovarian cancer

Targeted Anti-cancer Therapies (TAT) conference roundup

New antibody-drug conjugate shows early promise against all forms of melanoma

Prevention of cervical cancer through control of HPV virus

The global control and prevention of cervical cancer caused by HPV

Consensus on the treatment of breast cancer and early intervention using endocrine therapy

Biomarker development for ipilimumab and prostate GVAX treatment

Toll like receptor 7 agonists for cancer immunotherapy

Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

The 1st Immunotherapy of Cancer Conference (ITOC)

Reasons for combining immunotherapy with chemo to enhance anti tumour response